SPONSORED CONTENT
As portions of 340B savings shift from up-front discounts to post-adjudicated rebates, covered entities(CEs) face a new operational and accounting challenge. In the traditional discount model, the financial impact of a 340B transaction is immediate and measurable. In the rebate model, that clarity fractures into outcomes such as approved, denied, pending, reversed, or tied up in a Good-Faith Inquiry (GFI), each with distinct revenue-recognition implications.
While pharmacy teams have focused on workflows and submission readiness, the deeper effects land in the finance office, where revenue must be recognized according to defensible accounting principles and supported by data that has never lived in one place. When the underlying information lives in disparate systems, finance teams cannot effectively model realizability, forecast revenue recognition, or govern accruals with confidence because there is no single, high-integrity data source applying consistent modeling logic.
Proximity built its centralized rebate solution as part of its larger 340B Revenue Operations Platform by working closely with finance teams that anticipated what a rebate-based model would require long before it arrived. These teams recognized that the program’s underlying data and workflows were too inconsistent to support reliable forecasting or revenue governance once savings depended on a post-adjudication rebate model. Together, we designed a solution that unifies 340B program data into a single financial system of record capable of supporting the modeling, governance, and reconciliation that the rebate era demands.
As the industry enters this new phase, the need for centralized infrastructure that unifies data, tracks outcomes, and supports financial governance becomes increasingly clear. This is the emerging frontier of rebate-era 340B financial operations.
Why rebates behave like aged receivables, but with more volatility
In traditional revenue cycle management (RCM), aging receivables follow a predictable pattern. Clean claims move to payment, denials trigger workflows, and unresolved balances advance through aging buckets to realization or write-off. The rebate model introduces a similar pattern, but with materially greater uncertainty:
- Approved / Paid: revenue realized
- Denied / Not Paid: revenue written off
- Pending / No Decision: revenue held in accrual
- Good-Faith Inquiry: revenue under review
- Resubmission Required: revenue recoverable but unresolved
Unlike discounts, which provide immediate certainty, rebates can sit unresolved for long periods. Accounting principles require revenue to be recognized only when collection is probable and can be reasonably estimated. Variable timelines, multiple TPAs, and manufacturer-specific review policies make that probability hard to assess.
Many CEs could be submitting tens to hundreds of thousands of rebate-eligible claims in 2026. Even small percentages of denials or GFIs can create a large pool of aged accruals that must be monitored, reported, and substantiated.
The new data problem: finance needs information it has never been given
Finance teams need far more detail to manage rebate-era receivables. To accrue, forecast, and assess collectability, they need:
- Line-level purchasing information:
Which NDC was purchased, at what package size and price, and can the rebate be tied back to a specific acquisition cost? - Claim-level submission details:
What was submitted, when it was submitted, to which processor it was sent, and what baseline data was used? - Outcome-specific statuses:
Is the rebate approved, denied with rationale, pending without decision, or under GFI review? Each state has a different probability of collection. - Timeline history:
How long has the claim remained unresolved? Aging directly affects accrual treatment and adjustments.
Historically, no centralized system has supported this entire sequence end-to-end. Every link in the chain exists in multiple, disconnected locations. Wholesaler purchasing data is spread across vendors, claims data is scattered across multiple TPAs and in-house pharmacy systems, and rebate outcomes are beginning to flow into a new and largely untested processing layer. Even GFI documentation, one of the more financially consequential components, will continue to live as a manual workflow.
This fragmentation makes reconciliation fragile. Finance teams are expected to build a ledger from partial artifacts, without a unified record across purchases, claims, submissions, outcomes, and documentation. In practice, they are being asked to manage a receivable without the ledger that supports it.
Outcomes will likely appear slowly at first and then all at once: unreconciled claims age into uncertainty, GFI requests go untracked, and valid rebate dollars quietly disappear largely because the supporting data was never centralized.
Why aging matters: compliance and financial-reporting implications
As rebate claims accumulate in pending or GFI states, CEs face several compounding risks:
- Audit exposure
Auditors will require justification for recognition and aging. Unsupported accruals, or accruals based on incomplete data, invite findings. - Over-accrual risk
If accruals are based on historical discount expectations instead of actual rebate approval rates, revenue becomes overstated. - Under-accrual
Conservative accruals can create unpredictable swings when batches of payments finally arrive. - Operational volatility
Reversals and returns to stock for approved rebate claims can unwind previously recognized revenue. - Cash-flow uncertainty
Longer decision timelines, particularly if the ten-day processing window evolves, widen the gap between service delivery and revenue realization.
These risks mirror traditional RCM challenges when denial rates rise or payer timelines extend. When claims age without resolution, financial teams rely heavily on denial management tools and data-driven projections. The 340B rebate model requires similar rigor: centralized, systematic tracking of every dollar from purchase through final determination and the ability to model future outcomes.
Toward a unified reconciliation workflow
Forward-looking CEs now view 340B rebates as their own revenue cycle, requiring eligibility validation, submission audit, outcome tracking, GFI management, and reconciliation back to purchase data.
A durable reconciliation framework includes:
- A unified ledger connecting purchases, submissions, outcomes, and timelines
- Automated identification of claims at risk of denial or prolonged aging
- Standardized dispute and GFI management
- Predictive modeling using historical approval patterns
- Recurring reconciliation that links rebate receivables to underlying NDC purchases
This mirrors the infrastructure finance teams rely on in traditional RCM and now must extend into 340B.
Conclusion: Pharmacy may submit rebates, but Finance will own the risk
As the rebate model expands and timelines lengthen between service and cash receipt, CEs must prepare for significant portions of 340B savings to live temporarily or indefinitely in accrual. Finance will be responsible for managing a receivable that behaves very differently from the historical discount stream.
Organizations that invest early in data centralization, reconciliation workflows, and stronger collaboration between finance and pharmacy will be better positioned to maintain GAAP-aligned revenue recognition, avoid audit findings, stabilize cash flow, and prevent operational issues from becoming material financial risks.
CEs choosing a rebate solution should ensure it can support the criteria outlined above: unified purchasing and claims data, visibility into submission and outcome statuses, complete GFI tracking, robust aging and modeling, and end-to-end reconciliation. Without these elements, finance teams will be left managing a high-risk receivable without the information required to govern it effectively.
Proximity’s years of work alongside covered entities led to the development of a centralized 340B revenue operations platform built with pharmacy, finance, and compliance leaders who anticipated the shift from discounts to rebates and the fragmentation that would follow. As CEs now move into the rebate era, Proximity’s focus on operational integrity and financial governance provides the infrastructure needed to empower an accounting evolution that demands new data, new reconciliation processes, and a more unified approach to managing 340B revenue cycles.
Proximity is currently conducting their Demo Days series, which takes place every Monday, Wednesday, Friday at 11am central. Signup here for one of the sessions to learn more about Proximity’s rebate solution.
Scott Johnsen is founder and CEO of Proximity. For questions, please email scott@proximityhealth.com.
